Literature DB >> 29222399

Pediatric Disorders of Orthostatic Intolerance.

Julian M Stewart1, Jeffrey R Boris2, Gisela Chelimsky3, Phillip R Fischer4, John E Fortunato5, Blair P Grubb6, Geoffrey L Heyer7, Imad T Jarjour8, Marvin S Medow9, Mohammed T Numan10, Paolo T Pianosi4, Wolfgang Singer4, Sally Tarbell11, Thomas C Chelimsky3.   

Abstract

Orthostatic intolerance (OI), having difficulty tolerating an upright posture because of symptoms or signs that abate when returned to supine, is common in pediatrics. For example, ∼40% of people faint during their lives, half of whom faint during adolescence, and the peak age for first faint is 15 years. Because of this, we describe the most common forms of OI in pediatrics and distinguish between chronic and acute OI. These common forms of OI include initial orthostatic hypotension (which is a frequently seen benign condition in youngsters), true orthostatic hypotension (both neurogenic and nonneurogenic), vasovagal syncope, and postural tachycardia syndrome. We also describe the influences of chronic bed rest and rapid weight loss as aggravating factors and causes of OI. Presenting signs and symptoms are discussed as well as patient evaluation and testing modalities. Putative causes of OI, such as gravitational and exercise deconditioning, immune-mediated disease, mast cell activation, and central hypovolemia, are described as well as frequent comorbidities, such as joint hypermobility, anxiety, and gastrointestinal issues. The medical management of OI is considered, which includes both nonpharmacologic and pharmacologic approaches. Finally, we discuss the prognosis and long-term implications of OI and indicate future directions for research and patient management.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 29222399      PMCID: PMC5744271          DOI: 10.1542/peds.2017-1673

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  157 in total

1.  Mechanisms of post-flight orthostatic intolerance.

Authors:  C G Blomqvist; J C Buckey; F A Gaffney; L D Lane; B D Levine; D E Watenpaugh
Journal:  J Gravit Physiol       Date:  1994-05

2.  Insufficient flow reduction during LBNP in both splanchnic and lower limb areas is associated with orthostatic intolerance after bedrest.

Authors:  P Arbeille; P Kerbeci; L Mattar; J K Shoemaker; R Hughson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

Review 3.  Dehydration and cognitive performance.

Authors:  Ann C Grandjean; Nicole R Grandjean
Journal:  J Am Coll Nutr       Date:  2007-10       Impact factor: 3.169

4.  Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome.

Authors:  Qingyou Zhang; Ying Liao; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

Review 5.  Postural orthostatic tachycardia syndrome: a clinical review.

Authors:  Jonathan N Johnson; Kenneth J Mack; Nancy L Kuntz; Chad K Brands; Coburn J Porter; Philip R Fischer
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

6.  Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics.

Authors:  Walker B Plash; André Diedrich; Italo Biaggioni; Emily M Garland; Sachin Y Paranjape; Bonnie K Black; William D Dupont; Satish R Raj
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

7.  Objective Sleep Assessments in Patients with Postural Tachycardia Syndrome using Overnight Polysomnograms.

Authors:  Kanika Bagai; Amanda C Peltier; Beth A Malow; André Diedrich; Cyndya A Shibao; Bonnie K Black; Sachin Y Paranjape; Carlos Orozco; Italo Biaggioni; David Robertson; Satish R Raj
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

Review 8.  Aerobic exercise deconditioning and countermeasures during bed rest.

Authors:  Stuart M C Lee; Alan D Moore; Meghan E Everett; Michael B Stenger; Steven H Platts
Journal:  Aviat Space Environ Med       Date:  2010-01

9.  Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial.

Authors:  Even Fagermoen; Dag Sulheim; Anette Winger; Anders M Andersen; Johannes Gjerstad; Kristin Godang; Peter C Rowe; J Philip Saul; Eva Skovlund; Vegard Bruun Wyller
Journal:  BMC Pediatr       Date:  2015-09-10       Impact factor: 2.125

10.  Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS).

Authors:  Jake W Anderson; Elisabeth A Lambert; Carolina I Sari; Tye Dawood; Murray D Esler; Gautam Vaddadi; Gavin W Lambert
Journal:  Front Physiol       Date:  2014-06-25       Impact factor: 4.566

View more
  32 in total

Review 1.  Pathophysiology and Individualized Management of Vasovagal Syncope and Postural Tachycardia Syndrome in Children and Adolescents: An Update.

Authors:  Ying Liao; Junbao Du
Journal:  Neurosci Bull       Date:  2020-05-04       Impact factor: 5.203

2.  Near-infrared spectroscopy muscle oximetry of patients with postural orthostatic tachycardia syndrome.

Authors:  Parvathi Kadamati; Jeffrey J Sugar; Brendan J Quirk; Shima Mehrvar; Gisela G Chelimsky; Harry T Whelan; Thomas C Chelimsky; Mahsa Ranji
Journal:  J Innov Opt Health Sci       Date:  2018-08-13

3.  The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.

Authors:  Julian M Stewart; Archana Kota; Mary Breige O'Donnell-Smith; Paul Visintainer; Courtney Terilli; Marvin S Medow
Journal:  J Appl Physiol (1985)       Date:  2020-07-23

4.  The Pediatric Committee of the American Autonomic Society.

Authors:  Phillip R Fischer; Imad Jarjour; Erin L Marriott; Debra Weese-Mayer; Gisela Chelimsky
Journal:  Clin Auton Res       Date:  2018-02-22       Impact factor: 4.435

5.  The Benefits of Oral Rehydration on Orthostatic Intolerance in Children with Postural Tachycardia Syndrome.

Authors:  Marvin S Medow; Kenneth Guber; Shilpan Chokshi; Courtney Terilli; Paul Visintainer; Julian M Stewart
Journal:  J Pediatr       Date:  2019-08-09       Impact factor: 4.406

6.  Orthostatic heart rate does not predict symptomatic burden in pediatric patients with chronic orthostatic intolerance.

Authors:  Jeffrey R Boris; Jing Huang; Thomas Bernadzikowski
Journal:  Clin Auton Res       Date:  2019-08-05       Impact factor: 4.435

7.  Symptoms upon postural change and orthostatic hypotension in adolescents with concussion.

Authors:  M Nadir Haider; Kush S Patel; Barry S Willer; Victoria Videira; Charles G Wilber; Andrew R Mayer; Christina L Master; Brandon L Mariotti; Christopher Wertz; Eileen P Storey; Kristy B Arbogast; Grace Park; Scott J Oglesbee; Itai Bezherano; Kenneth Aguirre; Jesse G Fodero; Blair D Johnson; Rebekah Mannix; Jeffrey C Miecznikowski; John J Leddy
Journal:  Brain Inj       Date:  2021-01-17       Impact factor: 2.311

8.  Diagnostic Value of Diurnal Variability of Orthostatic Heart Rate Increment in Children and Adolescents With POTS.

Authors:  Hong Cai; Shuo Wang; Runmei Zou; Fang Li; Juan Zhang; Yuwen Wang; Yi Xu; Cheng Wang
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

9.  Chronic nausea and orthostatic intolerance: Diagnostic utility of orthostatic challenge duration, Nausea Profile Questionnaire, and neurohumoral measures.

Authors:  Ashley L Wagoner; Sally E Tarbell; Hossam A Shaltout; Debra I Diz; Debra E Weese-Mayer; John E Fortunato
Journal:  Neurogastroenterol Motil       Date:  2018-08-13       Impact factor: 3.598

Review 10.  Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency.

Authors:  Tessa Wassenberg; Jaap Deinum; Frans J van Ittersum; Erik-Jan Kamsteeg; Maartje Pennings; Marcel M Verbeek; Ron A Wevers; Mirjam E van Albada; Ido P Kema; Jorie Versmissen; Ton van den Meiracker; Jacques W M Lenders; Leo Monnens; Michèl A Willemsen
Journal:  J Inherit Metab Dis       Date:  2020-10-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.